Idrugs文章索引

期刊目录筛选

期刊名：Idrugs

缩写：

ISSN：1369-7056

e-ISSN：

IF/分区：0.0/

文章目录更多期刊信息

共收录本刊相关文章索引2149条

European Association for Clinical Pharmacology and Therapeutics--third congress. 3-7 October 1999, Jerusalem, Israel [0.03%] 欧洲临床药理与治疗协会会议(第三次会议)。1999年10月3日至7日，以色列耶路撒冷

J Hookes J Hookes

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1262-4. DOI: 1999

Late-breaker session II/new and emerging pathogens [0.03%] 最新研究进展（二）/新现和再现的病原体

Y Contrafouris Y Contrafouris

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1260-1. DOI: 1999

Late-breaker session I [0.03%] 最新研究报道会I

S Thomas S Thomas

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1258-9. DOI: 1999

Drug transport pumps: from molecular biology and pharmacology to clinical implications [0.03%] 药物转运泵：从分子生物学和药理学至临床意义

G Ecker G Ecker

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1256-7. DOI: 1999

Antifungal agents [0.03%] 抗真菌药

N S Ryder N S Ryder

At this year's ICAAC Meeting, new data on approximately 20 different antifungal agents were presented, while no new agents were disclosed. Drugs in late development include the triazoles, voriconazole (Pfizer Ltd) and Sch-56592 (Schering-Pl...

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1253-5. DOI: 1999

New antimicrobial agents [0.03%] 新型抗菌药

Y Contrafouris Y Contrafouris

This section covered one of the most eagerly awaited topics during this year's ICAAC meeting, the discovery of new agents against bacterial, fungal and viral disease. Compounds such as Microcide Pharmaceuticals Inc's MC-02479, Wyeth-Ayerst ...

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1250-2. DOI: 1999

Clinical highlights [0.03%] 临床亮点

Y Contrafouris Y Contrafouris

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1248-9. DOI: 1999

Quinolone update [0.03%] 喹诺酮类药物的最新研究进展

J F Barrett,L E Lawrence J F Barrett

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1244-7. DOI: 1999

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)--39th meeting. Antimicrobial compounds. 26-29 September 1999, San Francisco, CA, USA [0.03%] 第39届国际抗菌剂和化疗会议（ICAAC）抗微生物化合物1999年9月26～29日　美国加利福尼亚州旧金山市

D Pireh D Pireh

IDrugs : the investigational drugs journal. 1999 Dec;2(12):1241-3. DOI: 1999

Belaperidone (Knoll AG) [0.03%] 贝拉哌啶(霍夫曼-拉罗奇公司)

M D Tricklebank M D Tricklebank

Knoll is developing belaperidone, an antipsychotic agent, as a potential new treatment for schizophrenia. Phase II trials have commenced in Germany [200089,333710]. The compound is regarded as an atypical antipsychotic, similar in profile t...

IDrugs : the investigational drugs journal. 2000 Feb;3(2):228-31. DOI: 2000